Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies

Although there is no universally accepted definition of compulsive sexual behaviour (CSB), the term is generally used to indicate excessive sexual behaviour or sexual cognitions that lead to subjective distress, social or occupational impairment, or legal and financial consequences. Similar to impul...

Full description

Saved in:
Bibliographic Details
Published inInternational clinical psychopharmacology Vol. 17; no. 4; p. 201
Main Authors Raymond, N C, Grant, J E, Kim, S W, Coleman, E
Format Journal Article
LanguageEnglish
Published England 01.07.2002
Subjects
Adult
Drug Interactions
Female
Humans
Male
Middle Aged
Naltrexone - metabolism
Naltrexone - therapeutic use
Serotonin Uptake Inhibitors - metabolism
Serotonin Uptake Inhibitors - therapeutic use
Sexual Behavior - drug effects
Sexual Dysfunctions, Psychological - drug therapy
Sexual Dysfunctions, Psychological - psychology
Online AccessGet more information

Cover

More Information
Summary:Although there is no universally accepted definition of compulsive sexual behaviour (CSB), the term is generally used to indicate excessive sexual behaviour or sexual cognitions that lead to subjective distress, social or occupational impairment, or legal and financial consequences. Similar to impulse control disorders, CSB is characterized by a failure to resist the impulse for sex. Opioid antagonists have been effective in treating urge-driven disorders, such as pathological gambling disorder, alcoholism, borderline personality disorder with self-injurious behaviour, cocaine abuse, mental retardation with self-injurious behaviour and eating disorders. Based upon the efficacy of opioid antagonists in treating disorders associated with urges, we hypothesized that naltrexone would reduce both the urges associated with CSB and therefore reduce the sexual behaviour. We present two case reports of individuals with CSB treated successfully with naltrexone, a novel treatment for CSB. In both cases, symptoms dramatically decreased and psychosocial functioning improved with the use of naltrexone. Although more research is needed to determine the mechanism that leads to the excessive sexual behaviour in individuals with CSB, the present case reports suggest that naltrexone may be effective in treating some cases of CSB.
ISSN:0268-1315
DOI:10.1097/00004850-200207000-00008